跳至主要内容
临床试验/ACTRN12622000797774
ACTRN12622000797774尚未招募未知

Feasibility and Safety of Faecal Microbial Transplantation for Graft-Versus-Host Disease

Metro North Hospital and Health Service0 个研究点目标入组 10 人开始时间: 2022年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Recipient of allogeneic bone marrow transplantation
  • 2. Clinical and Histological diagnosis of gastrointestinal Graft-versus-Host Disease from any site in the GI tract.
  • 3. Steroid refractory (SR) and / or steroid dependent (SD) GVHD defined as;
  • - Progression after 3 days of 2mg/kg of Prednisone or equivalent.
  • - No change after 7 days of 2mg/kg of Prednisone or equivalent.
  • - Incomplete response (<50% reduction in stool volume) after 14 days of 2mg/kg of
  • Prednisone or equivalent.
  • - Recurrence on steroid taper when receiving >50mg of prednisolone per day.
  • 4. Ability to provide voluntary informed consent

排除标准

  • 1. Contraindication or inability to insert a naso-duodenal tube; including cytopenias which prevent safe insertion of naso-duodenal tube despite transfusional support.
  • 2. Active uncontrolled bacterial, fungal or viral infections
  • 3. Pregnancy or breast feeding

研究者

相似试验

Faecal Microbial Transplantation for... | 临床试验